Results 151 to 160 of about 2,137 (167)

Colonoscopic Fecal Bacteriotherapy in the Treatment of Recurrent Clostridium Difficile Infection - Results and Follow-up

American Journal of Gastroenterology, 2010
Mark H, Mellow, Amy, Kanatzar
openaire   +3 more sources

Combined Jejunal and Colonic Fecal Bacteriotherapy in Patients with Recurrent Clostridium Difficile Infection (RCDI)

American Journal of Gastroenterology, 2011
Mohit Girotra, John Bartlett, Kenda Koerner, Sudhir Dutta   +3 more
openaire   +2 more sources

Early Experience With a Fecal Bacteriotherapy (FB) Program for Recurrent and C-Difficile Infection (CDI)

Gastroenterology, 2011
Gilbert M. Wilcox
openaire   +2 more sources

Faculty Opinions recommendation of Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2011
Wendy Garrett, Michelle Rooks
openaire   +2 more sources

Barriers to Greater Utilization of Fecal Bacteriotherapy for Chronic Clostridium difficile Infection

American Journal of Gastroenterology, 2010
Colleen Kelly, Lauren de Leon, David Kerstetter, Nnenna Okpara   +3 more
openaire   +2 more sources

Successful Use of Fecal Bacteriotherapy in Severe Crohnʼs Colitis and Refractory Clostridium difficile Infection

American Journal of Gastroenterology, 2011
David You, Mark Johnson, Christopher Duplessis, Alissa Speziale   +3 more
openaire   +2 more sources

Changes in symptoms, distention-stimulated colonic motality and in fecal microbiological features after oral bacteriotherapy in patients with diarrhea-predominat IBS (D-IBS) or with functional diarrhea (FD)

The American Journal of Gastroenterology, 2002
Gabriele Bazzocchi
openaire   +2 more sources

Fecal Bacteriotherapy via Colonoscopy as Rescue Therapy for Refractory and Recurrent Clostridium difficile - Associated Diarrhea

American Journal of Gastroenterology, 2010
Brock C. Miller, Evan Dellon, Kim Isaacs, Lisa Gangarosa   +3 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

[Guideline for fecal bacteriotherapy to treat recurrent Clostridium difficile colitis].

Klinicka mikrobiologie a infekcni lekarstvi, 2019
We present a case of a 17-year-old female with anti-NMDAR encephalitis probably associated with vaccination against yellow fever. Her symptoms occurred 27 days after vaccination against yellow fever. Anti-NMDAR encephalitis manifested as acute psychosis, memory loss and catatonia following fever with complex partial epileptic seizures.
Silvia, Polívková, Lenka, Vojtilová, Petr, Husa, Jiří, Beneš   +3 more
openaire   +1 more source

[Fecal bacteriotherapy for the treatment of recurrent Clostridium difficile colitis used in the Clinic of Infectious Diseases of the University Hospital Brno in 2010-2014 - a prospective study].

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2016
The aim of the study is to assess the efficacy of fecal bacteriotherapy in the treatment of Clostridium difficile colitis.A prospective study of fecal bacteriotherapy in 80 adult patients hospitalized in the Clinic of Infectious Diseases, University Hospital Brno between 1 January 2010 and 31 December 2014.During the study period, 80 patients were ...
P, Polák, M, Freibergerová, P, Husa, J, Juránková, R, Svačinka, L, Mikešová, H, Kocourková, M, Mihalčin, R, Skalická, R, Stebel, M, Porubčanová   +10 more
openaire   +1 more source